Relapsing MS Treatment: Features and Benefits of a Proven Treatment Option (Sponsored)

Other search tools:Symptoms|Doctors|Medical Dictionary

Find us on:

WebMD Home

Relapsing MS Treatment: Know Your Options

Email a Friend

Print Article

This content is from our sponsor. The sponsor has sole editorial control.

Rebif is available in a prefilled, preassembled, and ready-to-use syringe so no premixing or assembly is required.
The Rebiject II^® auto-injector is designed to make injections easier and more convenient than the Rebif manual injection.
Rebif’s 3-times-weekly dosing schedule allows for injection-free weekends. Injections should be at least 48 hours apart.

Rebif's 3-times-weekly dosing schedule allows for injection-free weekends

The Rebiject II^® Auto-Injector

The Rebiject II^® auto-injector is designed to make injections easier than a manual Rebif injection. With the Rebiject II, the needle remains hidden both before and after injecting.

Rebiject II is designed for convenience and to reduce injection discomfort.

Benefits of Choosing Rebif

Relapsing MS can affect people differently. So can the medications used to treat it. A treatment may be right for one person, but it may not be the best choice for another. Talk to your doctor, and together, you can decide if Rebif is right for you.

Indication

Rebif is used to treat relapsing forms of MS to decrease the frequency of relapses and delay the occurrence of some of the physical disability that is common in people with MS. Rebif is not approved for treatment of chronic progressive MS. Rebif is available in 22 mcg and 44 mcg prefilled, preassembled syringes and a titration pack.

Important safety information

Before beginning treatment, patients should discuss with their doctor the potential benefits and risks associated with Rebif. Let your doctor know if you have a history of depression, seizures, liver disease, thyroid problems, or blood cell count or bleeding problems, or if you have had previous allergic reactions to medications. Tell your doctor about all medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements. Rebif and other medicines may affect each other causing serious side effects. Talk to your doctor before you take any new medicines. Rebif is not recommended for women who are or plan to become pregnant.

Potential serious side effects of Rebif include depression and risk of suicide, liver problems, risk to pregnancy, injection-site problems, and severe allergic reactions. Allergic reactions are rare and may be associated with difficulty in breathing and loss of consciousness, which require immediate medical attention.

The most common side effects with Rebif are injection-site reactions, flu-like symptoms (fever, chills, muscle aches, tiredness), depression, abdominal pain, elevated liver enzymes, and blood abnormalities.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

This information is not intended to replace discussions with your doctor. For additional information about Rebif, please consult the Medication Guide and talk to your doctor. You can also visit www.mslifelines.com or call toll-free 1-877-447-3243. Rebif is available by prescription only.

Rebif and MS LifeLines are registered trademarks of EMD Serono, Inc. or its affiliates.

Brought to you by EMD Serono, Inc. and Pfizer Inc, the co-marketers of
Rebif^® (interferon beta-1a) in the US.